{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T22:04:59Z","timestamp":1766268299198},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,8]]},"DOI":"10.7759\/cureus.10855","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T16:03:12Z","timestamp":1602172992000},"source":"Crossref","is-referenced-by-count":6,"title":["The Severity of Hepatitis D in Young Adults of Age 18-25 Years"],"prefix":"10.7759","author":[{"given":"Zaigham","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haider A","family":"Mandviwalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minaam","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale AJ","year":"2020","unstructured":"Stockdale AJ, Kreuels B, Henrion MYR, et al.. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020, 73:523-532. 10.1016\/j.jhep.2020.04.008","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i5.554","article-title":"Hepatitis D: scenario in the Asia-Pacific region","volume":"16","author":"Abbas Z","year":"2010","unstructured":"Abbas Z, Jafri W, Raza S. Hepatitis D: scenario in the Asia-Pacific region. World J Gastroenterol. 2010, 16:554-562. 10.3748\/wjg.v16.i5.554","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.9.3311-3316.2000","article-title":"Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains","volume":"38","author":"Flodgren E","year":"2000","unstructured":"Flodgren E, Bengtsson S, Knutsson M, Strebkova EA, Kidd AH, Alexeyev OA, Kidd-Ljunggren K. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol. 2000, 38:3311-3316. 10.1128\/JCM.38.9.3311-3316.2000","journal-title":"J Clin Microbiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-4-437","article-title":"Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment","volume":"98","author":"Rizzetto M","year":"1983","unstructured":"Rizzetto M, Verme G, Recchia S, et al.. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med. 1983, 98:437-441. 10.7326\/0003-4819-98-4-437","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical features of hepatitis D","volume":"32","author":"Farci P","year":"2012","unstructured":"Farci P, Niro GA. Clinical features of hepatitis D. Semin Liver Dis. 2012, 32:228-236. 10.1055\/s-0032-1323628","journal-title":"Semin Liver Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"Wedemeyer H","year":"2010","unstructured":"Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010, 7:31-40. 10.1038\/nrgastro.2009.205","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050103","article-title":"A retrospective study of the role of delta agent infection in children with HBsAg-positive chronic hepatitis","volume":"5","author":"Maggiore G","year":"1985","unstructured":"Maggiore G, Hadchouel M, Sessa F, et al.. A retrospective study of the role of delta agent infection in children with HBsAg-positive chronic hepatitis. Hepatology. 1985, 5:7-9. 10.1002\/hep.1840050103","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13556","article-title":"Hepatitis B virus-hepatitis D virus mother-to-child co-transmission: a retrospective study in a developed country","volume":"38","author":"Sellier PO","year":"2018","unstructured":"Sellier PO, Maylin S, Brichler S, et al.. Hepatitis B virus-hepatitis D virus mother-to-child co-transmission: a retrospective study in a developed country. Liver Int. 2018, 38:611-618. 10.1111\/liv.13556","journal-title":"Liver Int"},{"key":"ref9","article-title":"Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children","volume":"364","author":"Crax\u00ec A","year":"1991","unstructured":"Crax\u00ec A, Di Marco V, Volpes R, et al.. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children. Prog Clin Biol Res. 1991, 364:399-404.","journal-title":"Prog Clin Biol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000168","article-title":"Clinical presentation of hepatitis D in Pakistani children","volume":"26","author":"Abbas Z","year":"2014","unstructured":"Abbas Z, Soomro GB, Hassan SM, Luck NH. Clinical presentation of hepatitis D in Pakistani children. Eur J Gastroenterol Hepatol. 2014, 26:1098-1103. 10.1097\/MEG.0000000000000168","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12251","article-title":"Development and evaluation of a baseline-event-anticipation score for hepatitis delta","volume":"21","author":"Calle Serrano B","year":"2014","unstructured":"Calle Serrano B, Gro\u00dfhennig A, Homs M, et al.. Development and evaluation of a baseline-event-anticipation score for hepatitis delta. J Viral Hepat. 2014, 21:154-163. 10.1111\/jvh.12251","journal-title":"J Viral Hepat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000007","article-title":"Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan","volume":"26","author":"Butt FA","year":"2014","unstructured":"Butt FA, Amin I, Idrees M, Iqbal M. Hepatitis delta virus genotype-1 alone cocirculates with hepatitis B virus genotypes A and D in Pakistan. Eur J Gastroenterol Hepatol. 2014, 26:319-324. 10.1097\/MEG.0000000000000007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i18.2604","article-title":"Clinical presentation and genotype of hepatitis delta in Karachi","volume":"13","author":"Moatter T","year":"2007","unstructured":"Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol. 2007, 13:2604-2607. 10.3748\/wjg.v13.i18.2604","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03857.x","article-title":"Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan","volume":"20","author":"Mumtaz K","year":"2005","unstructured":"Mumtaz K, Hamid SS, Adil S, et al.. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. 2005, 20:1503-1507. 10.1111\/j.1440-1746.2005.03857.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.06.013","article-title":"Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan","volume":"64","author":"Aftab M","year":"2018","unstructured":"Aftab M, Amin I, Idrees M, Ali A, Rafique S, Naz S. Molecular epidemiology of hepatitis delta and hepatitis B viruses circulating in two major provinces (East and North-West) of Pakistan. Infect Genet Evol. 2018, 64:65-69. 10.1016\/j.meegid.2018.06.013","journal-title":"Infect Genet Evol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.8210","article-title":"Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis","volume":"13","author":"Amini N","year":"2013","unstructured":"Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis. Hepat Mon. 2013, 13:8210. 10.5812\/hepatmon.8210","journal-title":"Hepat Mon"},{"key":"ref17","article-title":"Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics","volume":"59","author":"Seetlani NK","year":"2009","unstructured":"Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafris W. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. JPMA J Pak Med Assoc. 2009, 59:434-437.","journal-title":"JPMA J Pak Med Assoc"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0369-8114(02)00351-6","article-title":"Hepatitis viruses: mother to child transmission (Article in French)","volume":"50","author":"Ranger-Rogez S","year":"2002","unstructured":"Ranger-Rogez S, Alain S, Denis F. Hepatitis viruses: mother to child transmission (Article in French). Pathol Biol (Paris). 2002, 50:568-575. 10.1016\/s0369-8114(02)00351-6","journal-title":"Pathol Biol (Paris)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2015.12.021","article-title":"Epidemiological and molecular features of hepatitis B and hepatitis delta virus transmission in a remote rural community in central Africa","volume":"39","author":"Fran\u00e7ois-Souqui\u00e8re S","year":"2016","unstructured":"Fran\u00e7ois-Souqui\u00e8re S, Makuwa M, Bisvigou U, Kazanji M. Epidemiological and molecular features of hepatitis B and hepatitis delta virus transmission in a remote rural community in central Africa. Infect Genet Evol. 2016, 39:12-21. 10.1016\/j.meegid.2015.12.021","journal-title":"Infect Genet Evol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15403\/jgld.2014.1121.244.dtv","article-title":"Hepatitis delta virus infection in Romania: prevalence and risk factors","volume":"24","author":"Gheorghe L","year":"2015","unstructured":"Gheorghe L, Csiki IE, Iacob S, et al.. Hepatitis delta virus infection in Romania: prevalence and risk factors. J Gastrointest Liver Dis. 2015, 24:413-421. 10.15403\/jgld.2014.1121.244.dtv","journal-title":"J Gastrointest Liver Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13604","article-title":"Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke A","year":"2018","unstructured":"Wranke A, Pinheiro Borzacov LM, Parana R, et al.. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN). Liver Int. 2018, 38:842-850. 10.1111\/liv.13604","journal-title":"Liver Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-8-420","article-title":"True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach","volume":"8","author":"Khan AU","year":"2011","unstructured":"Khan AU, Waqar M, Akram M, et al.. True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach. Virol J. 2011, 8:420. 10.1186\/1743-422X-8-420","journal-title":"Virol J"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104691","article-title":"The Delta-4 fibrosis score (D4FS): a novel fibrosis score in chronic hepatitis D","volume":"174","author":"Da BL","year":"2020","unstructured":"Da BL, Surana P, Kleiner DE, Heller T, Koh C. The Delta-4 fibrosis score (D4FS): a novel fibrosis score in chronic hepatitis D. Antiviral Res. 2020, 174:104691. 10.1016\/j.antiviral.2019.104691","journal-title":"Antiviral Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13205","article-title":"Non-invasive fibrosis score for hepatitis delta","volume":"37","author":"Lutterkort GL","year":"2017","unstructured":"Lutterkort GL, Wranke A, Yurdaydin C, et al.. Non-invasive fibrosis score for hepatitis delta. Liver Int. 2017, 37:196-204. 10.1111\/liv.13205","journal-title":"Liver Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.03.017","article-title":"Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir","volume":"46","author":"Borzacov LMP","year":"2016","unstructured":"Borzacov LMP, de Figueiredo Nicolete LD, Souza LFB, Dos Santos AO, Vieira DS, Salcedo JMV. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. Int J Infect Dis. 2016, 46:82-88. 10.1016\/j.ijid.2016.03.017","journal-title":"Int J Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2011.05.020","article-title":"Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America","volume":"11","author":"Alvarado-Mora MV","year":"2011","unstructured":"Alvarado-Mora MV, Romano CM, Gomes-Gouv\u00eaa MS, Gutierrez MF, Carrilho FJ, Pinho JRR. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America. Infect Genet Evol. 2011, 11:1462-1468. 10.1016\/j.meegid.2011.05.020","journal-title":"Infect Genet Evol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2728","article-title":"Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience","volume":"19","author":"Abbas Z","year":"2014","unstructured":"Abbas Z, Memon MS, Mithani H, Jafri W, Hamid S. Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience. Antivir Ther. 2014, 19:463-468. 10.3851\/IMP2728","journal-title":"Antivir Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42684-the-severity-of-hepatitis-d-in-young-adults-of-age-18-25-years","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:07Z","timestamp":1707506827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42684-the-severity-of-hepatitis-d-in-young-adults-of-age-18-25-years"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.10855","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,8]]}}}